feed,title,long_url,short_url
🔐MarketWatch,Philip Morris backs full-year profit guidance ahead of conference,http://www.marketwatch.com/news/story/philip-morris-backs-full-year-profit/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D72A8%2D6A640724A6EB%7D&siteid=rss,https://da.gd/RdeUVt
🔐MarketWatch,Replimune shares plunge as skin cancer therapy fails to meet primary clinical-trial goals,http://www.marketwatch.com/news/story/replimune-shares-plunge-skin-cancer/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D72A8%2D6970E5E2F8BD%7D&siteid=rss,https://da.gd/LFlFp
